发明名称 |
PHARMACEUTICAL INTERVENTION AND METHOD FOR TREATING AN APRAXIA OF SPEECH IN CHILDREN |
摘要 |
A pharmaceutical intervention and therapeutic method for treating an apraxia of speech in children. The child can also be diagnosed with gait abnormalities or impairment autism, mental retardation and dyslexia. If the child demonstrates at least an 18 to 24 month development stage of either verbal development or non-verbal development, a therapeutic dose of a dopamine agonistic, particularly a nonlinear lower alkyl phenidate or dextro-threo-methylphenidate is administered to the child. |
申请公布号 |
US2015283122(A1) |
申请公布日期 |
2015.10.08 |
申请号 |
US201514736406 |
申请日期 |
2015.06.11 |
申请人 |
Gilrose Pharmaceuticals, LLC |
发明人 |
ROSEMAN BRUCE;Kaplan Gilla |
分类号 |
A61K31/4458 |
主分类号 |
A61K31/4458 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating an apraxia of speech in a child in need of such treatment, said method comprises:
(a) administering a therapeutically effective dose of a dextro-methylphenidate to the child; whereby the apraxia of speech impairment is diminished. |
地址 |
White Plains NY US |